A study observed that PCSK9 levels in patients with a history of CAD are associated with high levels of circulating cholesterol, triglyceride, and inflammation which did not correspond to the severity and progression of the disease [82], although contradicting studies also exist [83]. This evidence concerns the gene PCSK9 and coronary artery disorder.